News | August 21, 2023
Venus Remedies launches its flagship R&D drug Elores in Oman
The antibacterial market in Oman is worth US $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025
The antibacterial market in Oman is worth US $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025
In March 2023, Japan’s Ministry of Health and Labor Welfare approved Novo Nordisk’s once-weekly subcutaneous glucagon-like peptide-1
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
PEEK brings a new quality to dental care for patients
Granules India sponsored an initiative to ignite a drug-free revolution and contribute towards an empowered society
LITFULO is the first and only treatment for severe alopecia areata approved for patients as young as 12
Ministry of Health, Labour and Welfare to evaluate zolbetuximab as treatment option for patients with advanced gastric and gastroesophageal cancers
The judicial response to industry lawsuits on drug pricing regulations have been mixed in the past
Data support that antibiotic aztreonam-avibactam (ATM-AVI) is effective and well-tolerated in treating infections caused by Gram-negative bacteria, with a similar safety profile to aztreonam alone
Concept Medical’s manufacturing arm has reduced its carbon footprint via in-house efficiency improvement programmes & green infrastructure
Subscribe To Our Newsletter & Stay Updated
